文献速递肿瘤 PET/CT核素与放射性配体治疗

原发前列腺癌中前列腺特异性膜抗原(PSMA)异质性与PSMA配体摄取检测:结合放射自显影与术后病理的研究

Heterogeneity of prostate-specific membrane antigen (PSMA) and PSMA-ligand uptake detection combining autoradiography and postoperative pathology in primary prostate cancer.
PubMed 文献 · EJNMMI Res · 2023-11-16

本研究纳入2018年11月至2020年1月接受放射性引导手术的17例原发前列腺癌患者,共分析4660个网格,比较99mTc-PSMA-I&S的瘤内分布与免疫组织病理。结果显示PSMA表达和PSMA配体摄取均呈现显著异质性,所有样本均见PSMA阴性灶,且两者异质性程度无显著相关;Gleason评分≥8分者摄取高于<8分者(p<0.001),Gleason模式4的出现与更高摄取强相关(系数0.43,p<0.001)。

要点

  • 17例原发前列腺癌患者共4660个网格分析显示PSMA表达存在显著瘤内和患者内异质性。
  • 所有样本(100%)均观察到PSMA阴性灶,患者内PSMA配体摄取亦呈异质性。
  • Gleason评分≥8分者PSMA配体摄取高于<8分者(p<0.001),Gleason模式4与更高摄取强相关(系数0.43,p<0.001)。

核心结论

  • PSMA表达和PSMA配体摄取均呈现显著异质性。
  • Gleason模式4的前列腺癌较非肿瘤前列腺组织摄取显著更高。
  • 分析将放射性标记PSMA配体的应用扩展至放射自显影,用于识别高级别病变并将其信号作为前列腺癌的无创生物标志物。

研究设计与样本

  • 初步分析纳入2018年11月至2020年1月接受放射性引导手术的17例患者,共分析4660个网格。
  • 采用99mTc-PSMA-I&S进行术后放射自显影,并与(免疫)组织病理学比较。

主要发现

  • 所有样本(100%)均观察到PSMA阴性灶,存在显著的瘤内和患者内PSMA表达异质性。
  • 患者内PSMA配体摄取呈异质性,PSMA表达异质性程度与PSMA配体摄取异质性程度之间无显著相关性。
  • Gleason评分≥8分者PSMA配体摄取高于Gleason评分<8分者(p<0.001)。
  • Gleason模式4的出现与更高摄取强相关(系数0.43,p<0.001),Gleason模式5也影响摄取(系数0.07,p<0.001)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Targeting prostate-specific membrane antigen (PSMA) has been highly successful for imaging and treatment of prostate cancer. However, heterogeneity in immunohistochemistry indicates limitations in the effect of imaging and radionuclide therapy of multifocal disease. 99mTc-PSMA-I&S is a γ-emitting probe, which can be used for intraoperative lesion detection and postsurgical autoradiography (ARG). We aimed to study its intraprostatic distribution and compared it with (immuno)-histopathology. RESULTS: Seventeen patients who underwent RGS between 11/2018 and 01/2020 with a total of 4660 grids were included in the preliminary analysis. Marked intratumor and intra-patient heterogeneity of PSMA expression was detected, and PSMA negative foci were observed in all samples (100%). Heterogeneous intra-patient PSMA-ligand uptake was observed, and no significant correlation was present between the degree of heterogeneity of PSMA expression and PSMA-ligand uptake. Higher PSMA-ligand uptake was observed in GS ≥ 8 than GS < 8 (p < 0.001). The appearance of Gleason Pattern (GP) 4 was strongly associated with higher uptake (coefficient: 0.43, p < 0.001), while GP 5 also affected the uptake (coefficient: 0.07, p < 0.001). CONCLUSION: PSMA expression and PSMA-ligand uptake show marked heterogeneity. Prostate carcinoma with GP 4 showed significantly higher uptake compared with non-neoplastic prostate tissue. Our analyses extend the scope of applications of radiolabeled PSMA-ligands to ARG for identifying high-grade disease and using its signal as a noninvasive biomarker in prostate cancer.

来源:EJNMMI Res,查看原文。版权归原作者所有。

引用

  1. Wang H, Remke M, Horn T, et al. Heterogeneity of prostate-specific membrane antigen (PSMA) and PSMA-ligand uptake detection combining autoradiography and postoperative pathology in primary prostate cancer. EJNMMI Res. 2023. PMID: 37971546. doi:10.1186/s13550-023-01044-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。